openPR Logo
Press release

AMOpportunities Closes its Series A at $5.4 Million

04-22-2021 10:12 AM CET | Health & Medicine

Press release from: AMOpportunities

AMOpportunities manages clinical training for schools, hospitals, and students globally.

AMOpportunities manages clinical training for schools, hospitals, and students globally.

AMOpportunities, the Chicago-based pioneer of Clinical Training as a Service (CTaaS) announced today that it has closed its Series A round a t $5.4 million. The round was led by OCA Ventures and co-led by HealthX Ventures (Madison, WI). Other investors include: PACE Healthcare, Chicago Early Growth Ventures, University of Chicago, Dreamit Ventures, and Wildcat LLC.

The company defines “clinical-training-as-a-service" as a platform that delivers clinical education sustainably for students, schools, and clinical sites such as hospitals.

All future doctors need clinical training to graduate and enter the healthcare workforce. Due to staffing issues and overburdened administrators, hospitals are often unable to easily support this need for hands on clinical training.

The world is predicted to be short 18 million healthcare workers by 2030, according to WHO. COVID-19 has exacerbated the problem and demonstrated what a future shortage could look like.

It’s clear a solution is needed. AMO is helping solve this serious problem by connecting hospitals, medical students, and medical schools on one easy-to-use CTaaS platform.
For medical schools, this means AMO helps increase enrollment capacity by connecting their students with hands-on clinical training opportunities. For hospitals, this provides increased medical talent and revenue, providing each hospital with up to $1.5 million a year in incremental revenue.

“AMO successfully navigated COVID-19, ending with a growth year due to exponential increases in demand from schools, hospitals, and students that will only continue in the coming years,” says Kyle Swinsky, CEO, AMOpportunities.

Through 2021, AMOpportunities will expand further into clinical training for nursing students.
“AMOpportunities is on their way to solving the impending healthcare shortage and fulfilling their mission of providing critical hands-on clinical learning opportunities for medical professionals,” says Bob Saunders, general partner, OCA Ventures.

AMOpportunities
444 N Wells St, Ste 601
Chicago, IL, 60654

Contact Info:
312.821.9020
advisors@amopportunities.org
www.amopportunities.org

Press Contact:
Brittany Trevick
AMOpportunities
612.743.2046
brittany@amopportunities.org

About AMOpportunities, Inc.
AMOpportunities, Inc., is a Chicago-based company that manages clinical training for schools, hospitals, and students globally. The company’s end-to-end software solution has provided more than 3,000 students rotations at 250-plus clinical sites. They count Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, UChicago Medicine, MedStar Georgetown University Hospital, Florida International University, and UI Health. More information at www.amopportunities.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AMOpportunities Closes its Series A at $5.4 Million here

News-ID: 2273538 • Views:

More Releases from AMOpportunities

Expanding Clinical Training: Ponce Health Sciences University, Mercy Health System, and AMOpportunities Partner to Support Underserved Communities
Expanding Clinical Training: Ponce Health Sciences University, Mercy Health Syst …
CHICAGO, August 24, 2021 – AMOpportunities, a Chicago-based company that provides medical students and graduates with clinical training across the United States, today announced a partnership with Ponce Health Sciences University (PHSU), an LCME-accredited medical school, and Missouri-based Mercy Hospital System to develop Mercy Hospital St. Louis into a clinical training site for PHSU’s MD program for medical students attending the new St. Louis campus. PHSU has a proven
AMOpportunities Launches Online Telehealth Clinical Experiences
AMOpportunities Launches Online Telehealth Clinical Experiences
The U.S. physician shortage is in the public spotlight given the COVID-19 public health crisis. However, the medical education system responsible for bolstering our ranks of physicians has ground to a standstill. Both international and U.S. medical students need clinical experiences to match into a U.S. residency program—the first training job any doctor must complete—to join the physician workforce and the fight against COVID-19. It was already projected pre-COVID

More Releases for AMO

Myotonic Dystrophy Pipeline Analysis 2024: FDA Approvals and Emerging Therapies, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Myotonic Dystrophy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Ophthalmology Phacoemulsification Market Detailed In New Research Report 2025 | …
Latest Report, titled "Ophthalmology Phacoemulsification Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Ophthalmology Phacoemulsification market has been expanding significantly
Myotonic Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Myotonic Dystrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myotonic Dystrophy Market. The Myotonic
Global Nanopatterning Market 2020 | AMO (Germany), Canadian Photonics Fabricatio …
In its as of recently distributed report, Market Research has given interesting experiences about Nanopatterning advertise for the given time frame. The Nanopatterning Market report offers fine insight that plans showcase players to contend well against their hardest rivals based on development, deals, and other indispensable components. The exploration study gives evaluations to Nanopatterning Forecast till 2025. A portion of the Leading key organizations Covered for this Research are AMO
Eye Care Solution Market Astonishing Growth| Alcon, Ciba Vision, Bausch, AMO, Co …
HTF MI recently introduced Global Eye Care Solution Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Alcon, Ciba Vision, Bausch, AMO, Cooper Vision, Menicon, Lenbert, Bescon
Intraocular Lens (IOLs) Market Strategic Analysis | Leading Key players ALCON, A …
HTF MI recently introduced Global Intraocular Lens (IOLs) Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are ALCON, AMO (Abbott), Bausch + Lomb, HOYA, CARL Zeiss, Ophtec,